ChemoCentryx to Host Virtual R&D Day on April 14, 2021
Thomas J. Schall, Ph.D., Presidentand Chief Executive Officer of ChemoCentryx
- Tausif (“Tosh”) Butt, Executive Vice President and Chief Operating Officer of
ChemoCentryx David Jayne, M.D., Director of the Vasculitis and Lupus Service, Addenbrooke’s Hospital in Cambridge Peter A. Merkel, M.D., MPH, Chief of Rheumatology and Professor of Medicine and Epidemiology at the University of Pennsylvania Glen Massie, Patient living with ANCA-associated vasculitis
Virtual R&D Day Information:
Wednesday, April 14, 2021
12:30pm– 3:00pm ET
- Live webcast link: https://wsw.com/webcast/cc/ccxi2/
Following completion of the live event, an archived webcast can be accessed through the Investors section of the Company’s website at www.ChemoCentryx.com, approximately two hours following the event. The archived webcast will remain available on the Company’s website for 60 days.
Executive Vice President,
Chief Financial and Administrative Officer
Source: ChemoCentryx, Inc.